TISSIUM

medical devices

About

TISSIUM is a medtech company founded in 2013 and based in Paris, France, with an office in Boston. The company focuses on developing and commercializing a unique biopolymer platform aimed at addressing challenges in tissue reconstruction and repair. TISSIUM's core innovation is its proprietary biomorphic programmable polymers, which are fully biosynthetic and can be customized to meet specific tissue needs. The product pipeline includes seven offerings across three main therapeutic areas: sutureless nerve repair, hernia repair, and cardiovascular sealants. Notably, TISSIUM's COAPTIUM® CONNECT is the first FDA-authorized system for atraumatic sutureless nerve coaptation available in the United States. The company also operates an ISO-certified manufacturing site in Roncq, France, supporting both internal programs and partnerships with other leaders in the medtech industry. TISSIUM has raised over $210 million in funding, enabling its innovative approach to tissue repair solutions.

Technologies

Outlook Nginx Mobile Friendly Ruby On Rails WordPress.org Hubspot Google Font API Remote AI

Keywords

medical device medtech synthetic polymers tissue reconstruction innovation medical equipment manufacturing hernia mesh fixation drug-eluting polymers co-development partnerships 3d printing in surgery advanced biomaterials polymer-based nerve coaptation tissue-specific polymer customization biomorphic programmable polymers minimally traumatic surgery regenerative medicine vascular sealant b2b biomorphic polymers biopolymer delivery systems polymer-based tissue adhesives medical devices surgical scaffolds sutureless nerve repair resorbable surgical implants blue light polymerization surgical equipment biocompatible elastomers tissue conformability surgical sealants

Location

74 Rue du Faubourg Saint-Antoine, Paris, Ile-de-France, France, 75012

Related Companies

Companies in the same industry